1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Acute Ischemic Stroke-Pipeline Insights, 2017


DelveInsight’s, “ Acute Ischemic Stroke-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Acute Ischemic Stroke. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Acute Ischemic Stroke. DelveInsight’s Report also assesses the Acute Ischemic Stroke therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Please note:This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication.

Scope

- The report provides competitivepipeline landscape of Acute Ischemic Stroke
- The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
- Coverage of the Acute Ischemic Stroke pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
- The report reviews key players involved in the therapeutics development for Acute Ischemic Stroke and also provide company profiling
- The report also gives the information of dormant and discontinued pipeline projects
- Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

Table Of Contents

Acute Ischemic Stroke-Pipeline Insights, 2017
Illustrative

- Acute Ischemic Stroke Overview
- Acute Ischemic Stroke Pipeline Therapeutics
- Acute Ischemic Stroke Therapeutics under Development by Companies
- Acute Ischemic Stroke Filed and Phase III Products
- Comparative Analysis
- Acute Ischemic Stroke Phase II Products
- Comparative Analysis
- Acute Ischemic Stroke Phase I and IND Filed Products
- Comparative Analysis
- Acute Ischemic Stroke Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Acute Ischemic Stroke - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Acute Ischemic Stroke - Discontinued Products
- Acute Ischemic Stroke - Dormant Products
- Companies Involved in Therapeutics Development for Acute Ischemic Stroke
- Appendix
- Methodology
- Contact Us
- Disclaimer


List of Tables

- Number of Products under Development for Acute Ischemic Stroke, 2017
- Number of Products under Development by Companies
- Comparative Analysis by Filed and Phase III Products, 2017
- Comparative Analysis Phase II Products, 2017
- Comparative Analysis Phase I and IND Filed Products, 2017
- Comparative Analysis Discovery and Pre-Clinical Stage Products, 2017
- Drug Candidates Profiles
- Acute Ischemic Stroke Assessment by Monotherapy Products
- Acute Ischemic Stroke Assessment by Combination Products
- Acute Ischemic Stroke Assessment by Route of Administration
- Acute Ischemic Stroke Assessment by Stage and Route of Administration
- Acute Ischemic Stroke Assessment by Molecule Type
- Acute Ischemic Stroke Assessment by Stage and Molecule Type
- Acute Ischemic Stroke Therapeutics - Discontinued Products
- Acute Ischemic Stroke Therapeutics - Dormant Products
- Products under Development by Companies, 2017


List of Figures

- Number of Products under Development for Acute Ischemic Stroke, 2017
- Filed and Phase III Products, 2017
- Phase II Products, 2017
- Phase I and IND Filed Products, 2017
- Discovery and Pre-Clinical Stage Products, 2017
- Acute Ischemic Stroke Assessment by Monotherapy Products
- Acute Ischemic Stroke Assessment by Combination Products
- Acute Ischemic Stroke Assessment by Route of Administration
- Acute Ischemic Stroke Assessment by Stage and Route of Administration
- Acute Ischemic Stroke Assessment by Molecule Type
- Acute Ischemic Stroke Assessment by Stage and Molecule Type

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Acute ischemic stroke (AIS)- Market Insights, Epidemiology and Market Forecast-2023

Acute ischemic stroke (AIS)- Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • January 2017
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Acute ischemic stroke (AIS) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease ...

Acute ischemic stroke (AIS) - Epidemiology Forecast To 2023

Acute ischemic stroke (AIS) - Epidemiology Forecast To 2023

  • $ 2750
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight “Acute ischemic stroke (AIS) - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Acute ischemic stroke (AIS) in seven major markets (US, France, Germany, ...

Global Thrombectomy Devices Market 2016-2020

Global Thrombectomy Devices Market 2016-2020

  • $ 2500
  • Industry report
  • December 2016
  • by Infiniti Research Limited

About Thrombectomy Devices Over the years, majority of the minimally invasive cardiovascular surgeries have been increasingly using atherectomy and thrombectomy devices to increase the success rate of ...

Stroke-api Insights, 2017

January 2017 $ 1250

ref:plp2017

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.